HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward E Tredget Selected Research

Decorin

1/2021Stimulation of toll-like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring.
11/2016Serum Decorin, Interleukin-1β, and Transforming Growth Factor-β Predict Hypertrophic Scarring Postburn.
8/2015A novel subpopulation of peripheral blood mononuclear cells presents in major burn patients.
1/2015MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar.
10/2012Differential expression of class I small leucine-rich proteoglycans in an animal model of partial bladder outlet obstruction.
9/2012Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring.
3/2012Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring.
5/2011Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward E Tredget Research Topics

Disease

36Wounds and Injuries (Trauma)
01/2021 - 05/2002
34Cicatrix (Scar)
01/2022 - 09/2002
29Burns
01/2022 - 08/2002
17Hypertrophic Cicatrix (Hypertrophic Scar)
01/2022 - 03/2004
10Fibrosis (Cirrhosis)
01/2022 - 05/2002
5Inflammation (Inflammations)
12/2017 - 09/2008
4Infections
01/2021 - 08/2002
3Contact Dermatitis (Eczema, Contact)
03/2010 - 09/2008
2Contracture
01/2017 - 11/2009
2Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
03/2015 - 10/2012
1Reinjuries
01/2022
1Compartment Syndromes
01/2021
1Critical Illness (Critically Ill)
12/2018
1Sepsis (Septicemia)
01/2017
1Vitamin D Deficiency
09/2016
1Hypertrophy
03/2015
1Carcinogenesis
06/2014
1Ulcer
06/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2012
1Chemical Burns (Chemical Burn)
07/2012
1Lung Diseases (Lung Disease)
03/2012

Drug/Important Bio-Agent (IBA)

26CollagenIBA
01/2022 - 05/2002
8DecorinIBA
01/2021 - 05/2011
7CytokinesIBA
12/2017 - 07/2005
6Biological ProductsIBA
01/2022 - 09/2007
6Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2007
5Transforming Growth Factor beta (TGF-beta)IBA
07/2007 - 09/2002
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 07/2008
4Conditioned Culture MediaIBA
08/2015 - 01/2007
4Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2007 - 05/2002
3Small Leucine-Rich ProteoglycansIBA
01/2021 - 05/2011
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016 - 12/2010
3Chemokine CXCL12IBA
08/2015 - 09/2011
3CXCR4 Receptors (CXCR4 Receptor)IBA
08/2015 - 09/2011
3Collagen Type I (Type I Collagen)IBA
11/2012 - 09/2002
3Procollagen Type IIBA
11/2012 - 05/2002
3SilverIBA
03/2010 - 09/2008
3Interferon-alpha2bIBA
07/2008 - 10/2005
3Messenger RNA (mRNA)IBA
03/2006 - 05/2002
2Proteoglycans (Proteoglycan)IBA
01/2022 - 01/2022
2Extracellular Matrix ProteinsIBA
01/2022 - 03/2004
2BiglycanIBA
01/2021 - 10/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2021 - 05/2011
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 10/2012
2Collagen Type III (Type III Collagen)IBA
01/2020 - 03/2004
2ChemokinesIBA
11/2015 - 09/2014
2Toll-Like Receptor 4IBA
08/2015 - 05/2011
2ProcollagenIBA
08/2015 - 03/2004
2Connective Tissue Growth FactorIBA
11/2012 - 12/2010
2FibromodulinIBA
03/2012 - 05/2011
2InterferonsIBA
09/2011 - 10/2005
2Dinitrochlorobenzene (DNCB)IBA
02/2010 - 09/2008
2AminoglycosidesIBA
07/2007 - 02/2004
2Neutralizing AntibodiesIBA
07/2007 - 01/2007
2Hydroxyproline (4 Hydroxyproline)IBA
01/2007 - 01/2004
1Protein Isoforms (Isoforms)IBA
01/2022
1Colloids (Colloid)IBA
08/2021
1AlbuminsIBA
08/2021
1Crystalloid SolutionsIBA
08/2021
1PutrescineIBA
01/2020
1Therapeutic UsesIBA
01/2020
1Amino AcidsFDA Link
01/2020
1Protein Glutamine gamma Glutamyltransferase 2IBA
01/2020
1Lysine (L-Lysine)FDA Link
01/2020
1SiliconesIBA
05/2017
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
01/2017
1PlasticsIBA
01/2017
1Alkaline PhosphataseIBA
12/2016
1Bone Morphogenetic Protein 4IBA
12/2016
1HydrogelsIBA
12/2016
1EnzymesIBA
11/2016
1ImmunosorbentsIBA
11/2016
1Vitamin DFDA LinkGeneric
09/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2015
1Tadalafil (Cialis)FDA Link
03/2015
1Prednisone (Sone)FDA LinkGeneric
03/2015
1MicroRNAs (MicroRNA)IBA
01/2015
1CXC ChemokinesIBA
09/2014
1CTCE-9908IBA
09/2014
1SolutionsIBA
08/2014
1matrigelIBA
02/2013
1HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
11/2012
1ChlorineIBA
07/2012
1Oxygen (Dioxygen)IBA
03/2012

Therapy/Procedure

10Therapeutics
01/2021 - 03/2006
4Lasers (Laser)
01/2022 - 11/2012
4Resuscitation
08/2021 - 09/2005
3Aftercare (After-Treatment)
09/2011 - 11/2002
2Skin Transplantation (Skin Grafting)
01/2021 - 03/2012
2Blood Transfusion (Blood Transfusions)
10/2019 - 12/2018
2Artificial Skin
07/2015 - 10/2011
2Transplantation
03/2011 - 01/2006
1Laser Therapy (Surgery, Laser)
01/2022
1Abdominoplasty
01/2021
1Artificial Respiration (Mechanical Ventilation)
10/2019
1Radiotherapy
06/2014
1Stem Cell Transplantation
02/2013
1Extracorporeal Membrane Oxygenation
07/2012
1Length of Stay
03/2012
1Long-Term Care
03/2012